Rakuten Investment Management Inc. Takes Position in Guardian Pharmacy Services, Inc. $GRDN

Rakuten Investment Management Inc. purchased a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 16,493 shares of the company’s stock, valued at approximately $433,000.

A number of other hedge funds also recently bought and sold shares of GRDN. State of Alaska Department of Revenue bought a new position in Guardian Pharmacy Services in the third quarter valued at about $30,000. Parkside Financial Bank & Trust purchased a new stake in shares of Guardian Pharmacy Services during the 2nd quarter valued at about $41,000. Raymond James Financial Inc. purchased a new stake in shares of Guardian Pharmacy Services during the 2nd quarter valued at about $43,000. Police & Firemen s Retirement System of New Jersey lifted its stake in shares of Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after purchasing an additional 1,062 shares during the period. Finally, State of Wyoming purchased a new position in shares of Guardian Pharmacy Services in the second quarter worth approximately $58,000.

Guardian Pharmacy Services Stock Up 0.4%

NYSE GRDN opened at $30.51 on Monday. Guardian Pharmacy Services, Inc. has a twelve month low of $17.78 and a twelve month high of $37.43. The business has a 50-day moving average price of $29.82 and a 200-day moving average price of $26.79. The firm has a market cap of $1.93 billion, a price-to-earnings ratio of 48.43 and a beta of 0.96.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Monday, November 10th. The company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.01. The company had revenue of $377.43 million for the quarter, compared to analysts’ expectations of $381.16 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%. Research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

GRDN has been the subject of a number of research reports. Truist Financial upped their target price on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a report on Friday, November 14th. Wall Street Zen raised shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 17th. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Stephens raised their target price on Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, January 14th. Finally, Oppenheimer assumed coverage on Guardian Pharmacy Services in a report on Friday, October 10th. They set an “outperform” rating and a $30.00 price target for the company. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $32.00.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.